Related Experiment Video
Updated: Jun 18, 2026

05:47
Isolation and Transplantation of Different Aged Murine Thymic Grafts.
Published on: May 13, 2015
[Study on relationship between chemical castration and thymic function following hematopoietic stem cell
Xiao-dan Luo1, Qi-fa Liu, Juan Ning
1Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|December 4, 2009
Summary
Luteinizing hormone-releasing hormone (LHRH) treatment reduced the severity of graft-versus-host disease (GVHD) and thymic damage after allogeneic hematopoietic stem cell transplantation (allo-HSCT). This protection may involve lowering intracellular interferon-gamma levels in thymocytes.
Area of Science:
- Immunology and Transplantation Biology
- Endocrinology and Reproductive Medicine
Context:
- Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a life-saving procedure but is complicated by graft-versus-host disease (GVHD).
- The thymus plays a critical role in immune reconstitution post-transplantation, and its function is often impaired after allo-HSCT.
- Luteinizing hormone-releasing hormone (LHRH) and its analogs have immunomodulatory properties that warrant investigation in transplantation settings.
Purpose:
- To investigate the protective effects of LHRH on thymic function following allo-HSCT in a murine model.
- To assess the impact of LHRH on the severity of acute GVHD and associated cytokine profiles.
- To explore the potential mechanisms underlying LHRH's protective effects on the thymus.
Summary:
- A murine model of MHC-mismatched allo-HSCT was utilized to evaluate LHRH's impact.
- LHRH treatment significantly reduced the severity of acute GVHD and protected thymic function, indicated by lower levels of pro-inflammatory cytokines like IFN-gamma, TNF-alpha, and IL-1 beta in thymocytes.
- While hematopoietic reconstitution was achieved in all groups, LHRH-treated mice exhibited milder GVHD and reduced thymic damage compared to controls.
Impact:
- LHRH administration demonstrates a therapeutic potential in mitigating GVHD and preserving thymic function after allo-HSCT.
- The findings suggest that LHRH's mechanism of action may involve the modulation of intracellular cytokine production within thymocytes.
- This study provides a basis for exploring LHRH-based strategies to improve outcomes in allo-HSCT recipients.

